+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Adrenergic uptake inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenergic uptake inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adrenergic Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenergic Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Beta Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Cholesterol Absorption Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cholesterol Absorption Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
VAP-1 Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

VAP-1 Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Renin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Renin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Beta Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Angiotensin Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin Modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Beta-1 Receptors Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
PDE 1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

PDE 1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
PDE Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PDE Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Beta-2 Receptors Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-2 Receptors Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more